The Stable Gastric Pentadecapeptide BPC 157 Pleiotropic Beneficial Activity and Its Possible Relations with Neurotransmitter Activity
Sikiric P, Drmic D, Boban Blagaic A, et al.
Pharmaceuticals, 2024
Key finding
BPC-157 demonstrates broad cytoprotective activity mediated through interactions with multiple neurotransmitter systems and the NO system, functioning as a unique cytoprotection mediator stable in gastric juice.
Summary
Major 2024 review covering BPC-157 pleiotropic effects across organ systems, including its interactions with the dopamine, serotonin, GABA, and NO systems. Notes BPC-157 is not destroyed in human gastric juice.
Read the study
The full citation, abstract, and (when available) the full text can be accessed on PubMed. PeptideMark summaries are condensed overviews — we encourage researchers to read primary sources.
View on PubMedRelated compound
More research on BPC-157
Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review
Sports Health · 2025 · Review
Safety of Intravenous Infusion of BPC157 in Humans: A Pilot Study
Alternative Therapies in Health and Medicine · 2025 · Human Pilot
Stable Gastric Pentadecapeptide BPC 157 and Wound Healing
Frontiers in Pharmacology · 2021 · Review
Modulatory effects of BPC 157 on vasomotor tone and the activation of Src-Caveolin-1-endothelial nitric oxide synthase pathway
Scientific Reports · 2020 · Animal Study
Pentadecapeptide BPC 157 Enhances the Growth Hormone Receptor Expression in Tendon Fibroblasts
Molecules · 2014 · In Vitro